← Leaderboards
Clive Niels Svendsen
University Of Wisconsin Madison
$19,591,596
Attributed
$34,000,642
Total exposure
25
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$51,169,222 · 27
By mechanism
U54$19,232,677 · 5
UG3$10,182,638 · 4
P01$7,402,232 · 4
UH3$6,964,423 · 3
RC2$3,776,244 · 1
R44$1,462,639 · 1
Top collaborators
- Leslie Michels Thompson35 shared
- Steven M Finkbeiner34 shared
- Ernest Fraenkel31 shared
- Jeffrey D Rothstein31 shared
- Nureddin Ashammakhi5 shared
- Nigel T Maidment5 shared
- Stephanie Kristin Seidlits5 shared
- James F Gusella3 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsBaseNeuronsInduced Pluripotent Stem CellResponseCell TypeTechnologyGeneticCollaborationsInnovationTissuesCommunitiesAstrocytesPharmaceutical PreparationsMotor NeuronsCell LineProteomicsResourcesNeurogliaAmyotrophic Lateral SclerosisMolecularGenesFoundationsScientist
Grant awards (86)
Using microgravity to model inflammaging in complex organ chip models of heart, gut, and brain$1,202,427
UG3 · FY2025 · AG
Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool.$793,584
UH3 · FY2024 · TR
A microphysiologic multicellular organ-on-chip to inform clinical trials in FTD/ALS$697,574
UH3 · FY2024 · TR · contact PI
Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool.$793,584
UH3 · FY2023 · TR
A microphysiologic multicellular organ-on-chip to inform clinical trials in FTD/ALS$708,245
UH3 · FY2023 · TR · contact PI
Development of a Microphysiological Organ-on-Chip System to Model Amyotrophic$1,174,019
UH3 · FY2022 · NS · contact PI
Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool.$793,652
UH3 · FY2022 · TR
A microphysiologic multicellular organ-on-chip to inform clinical trials in FTD/ALS$792,246
UH3 · FY2022 · TR · contact PI
Development of a Microphysiological Organ-on-Chip System to Model Amyotrophic$1,211,519
UH3 · FY2021 · NS · contact PI
A microphysiologic multicellular organ-on-chip to inform clinical trials in FTD/ALS$800,773
UG3 · FY2021 · TR · contact PI
Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool.$531,057
UG3 · FY2021 · TR
A Lung-chip microphysiological system to model SARS-CoV-2 infection and test novel therapeutics$1,163,750
UG3 · FY2020 · NS · contact PI
A microphysiologic multicellular organ-on-chip to inform clinical trials in FTD/ALS$825,123
UG3 · FY2020 · TR · contact PI
Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$600,000
U54 · FY2020 · NS
Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal and the negative affective component of pain: a therapeutic screening tool.$1,603,492
UG3 · FY2019 · TR
Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$1,422,765
U54 · FY2019 · NS
Development of a Microphysiological Organ-on-Chip System to Model Amyotrophic$1,248,105
UG3 · FY2019 · NS · contact PI
Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$1,334,000
U54 · FY2018 · NS
Development of a Microphysiological Organ-on-Chip System to Model Amyotrophic$1,253,405
UG3 · FY2018 · NS · contact PI
Data Generation Core - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$934,287
U54 · FY2018 · NS
Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$833,765
U54 · FY2018 · NS
Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells-Supplement$418,818
U54 · FY2018 · NS
Effects of opioids on reward systems in organ chips$330,851
UG3 · FY2018 · NS · contact PI
Data Analysis & sig - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$323,790
U54 · FY2018 · NS
Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells-Supplement$107,536
U54 · FY2018 · NS
Administration - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$55,908
U54 · FY2018 · NS
Community Interactions Outreach - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$20,015
U54 · FY2018 · NS
Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$2,167,765
U54 · FY2017 · NS
Data Generation Core - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$1,527,239
U54 · FY2017 · NS
Development of a Microphysiological Organ-on-Chip System to Model Amyotrophic$1,223,655
UG3 · FY2017 · NS · contact PI
Data Analysis & sig - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$520,751
U54 · FY2017 · NS
Tracking cardiac engraftment and viability of MiPSC by MRI$479,285
R44 · FY2017 · EB
Administration - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$87,390
U54 · FY2017 · NS
Community Interactions Outreach - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$32,385
U54 · FY2017 · NS
Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$1,334,000
U54 · FY2016 · NS
Tracking cardiac engraftment and viability of MiPSC by MRI$983,354
R44 · FY2016 · EB
Data Generation Core - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$934,285
U54 · FY2016 · NS
Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$833,765
U54 · FY2016 · NS
Data Analysis & sig - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$323,788
U54 · FY2016 · NS
Administration - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$55,910
U54 · FY2016 · NS
Community Interactions Outreach - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$20,017
U54 · FY2016 · NS
Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$8,498
U54 · FY2016 · NS
Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$1,334,000
U54 · FY2015 · NS
Data Generation Core - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$934,286
U54 · FY2015 · NS
Data Analysis & sig - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$317,686
U54 · FY2015 · NS
A genetic model of inflammatory bowel disease using human intestinal organoids.$262,500
R56 · FY2015 · DK
Administration - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$55,910
U54 · FY2015 · NS
Community Interactions Outreach - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$26,118
U54 · FY2015 · NS
Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$1,334,000
U54 · FY2014 · NS
Data Generation Core - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$940,394
U54 · FY2014 · NS
Data Analysis & sig - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$310,155
U54 · FY2014 · NS
Administration - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$55,910
U54 · FY2014 · NS
Community Interactions Outreach - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells$27,541
U54 · FY2014 · NS
An iPS Disease-in-a-Dish Model of Familial Alzheimers$368,456
RF1 · FY2012 · AG
Stem Cell Therapy and Growth Factor Therapy for ALS$960,075
P01 · FY2011 · NS · contact PI
Astrocytes Producting Growth Factors for ALS$277,858
P01 · FY2011 · NS · contact PI
Histology & Imaging$64,511
P01 · FY2011 · NS · contact PI
The Huntington's Disease iPS Consortium$1,839,894
RC2 · FY2010 · NS
Stem Cell Therapy and Growth Factor Therapy for ALS$992,012
P01 · FY2010 · NS · contact PI
Astrocytes Producting Growth Factors for ALS$278,984
P01 · FY2010 · NS · contact PI
The Huntington's Disease iPS Consortium$76,500
RC2 · FY2010 · NS
Histology & Imaging$67,289
P01 · FY2010 · NS · contact PI
The Huntington's Disease iPS Consortium$1,859,850
RC2 · FY2009 · NS
Stem Cell Therapy and Growth Factor Therapy for ALS$1,166,338
P01 · FY2009 · NS · contact PI
Astrocytes Producting Growth Factors for ALS$337,203
P01 · FY2009 · NS · contact PI
Directing the Fate of Neural Stem Cells with Engineered Gradients of FGF-2$162,422
R21 · FY2009 · NS · contact PI
Histology & Imaging$78,055
P01 · FY2009 · NS · contact PI
SHARING IN THE DISCOVERY STEM CELL LEARNING LAB$46,835
P51 · FY2009 · RR · contact PI
Stem Cell Therapy and Growth Factor Therapy for ALS$1,144,072
P01 · FY2008 · NS · contact PI
Astrocytes Producting Growth Factors for ALS$327,191
P01 · FY2008 · NS · contact PI
Directing the Fate of Neural Stem Cells with Engineered Gradients of FGF-2$194,906
R21 · FY2008 · NS · contact PI
Stem Cell Research Training Program$167,256
T32 · FY2008 · AG · contact PI
SHARING IN THE DISCOVERY STEM CELL LEARNING LAB$81,915
P51 · FY2008 · RR · contact PI
Histology & Imaging$75,737
P01 · FY2008 · NS · contact PI
Stem Cell Therapy and Growth Factor Therapy for ALS$1,177,171
P01 · FY2007 · NS · contact PI
Astrocytes Producting Growth Factors for ALS$315,299
P01 · FY2007 · NS · contact PI
Stem Cell Research Training Program$160,641
T32 · FY2007 · AG · contact PI
Histology & Imaging$75,832
P01 · FY2007 · NS · contact PI
Adminstrative Core$64,605
P01 · FY2007 · NS · contact PI
Stem Cell Research Training Program$156,356
T32 · FY2006 · AG · contact PI
DERIVATION OF EMBRYONIC STEM CELLS FOR STUDYING PARKINSON'S DISEASE$27,215
P51 · FY2006 · RR · contact PI
Stem Cell Research Training Program$163,830
T32 · FY2005 · AG
DERIVATION OF VERVET EMBRYONIC STEM CELLS FOR STUDYING PARKINSON'S DISEASE$34,795
P51 · FY2005 · RR
VERVET EMBRYONIC STEM CELLS FOR STUDYING PARKINSON'S$572
P51 · FY2004 · RR
CORE--ANIMAL CARE AND BREEDING$160,335
P30 · FY2002 · HD
CORE--ANIMAL CARE AND BREEDING$160,335
P30 · FY2001 · HD